{"id":"NCT01148459","sponsor":"GlaxoSmithKline","briefTitle":"Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children","officialTitle":"Safety and Immunogenicity Study of GSK Biologicals' Plasmodium Falciparum Malaria Vaccine 257049 Administered to HIV Infected Infants and Children","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-07-30","primaryCompletion":"2013-05-24","completion":"2013-05-24","firstPosted":"2010-06-22","resultsPosted":"2019-01-16","lastUpdate":"2019-01-16"},"enrollment":200,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Malaria"],"interventions":[{"type":"BIOLOGICAL","name":"GSK Biological's Investigational Malaria Vaccine 257049","otherNames":[]},{"type":"BIOLOGICAL","name":"Human Diploid Cell Vaccine (HDCV) or Purified Vero Cell Rabies Vaccine (PVRV, Verorab) (Aventis Pasteur);","otherNames":[]},{"type":"BIOLOGICAL","name":"Purified Chick Embryo Cell Culture (PCEC) Rabies Vaccine (Rabipur or equivalent) (Novartis).","otherNames":[]}],"arms":[{"label":"Group A","type":"EXPERIMENTAL"},{"label":"Group B","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the safety and immunogenicity of the candidate malaria vaccine in HIV-infected infants and children","primaryOutcome":{"measure":"Number of Subjects With Serious Adverse Events (SAEs)","timeFrame":"During the entire study period (from 30 days before Dose 1 up to Month 14)","effectByArm":[{"arm":"GSK257049 Group","deltaMin":41,"sd":null},{"arm":"Verorab Group","deltaMin":37,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Weeks","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":12},"locations":{"siteCount":2,"countries":["Kenya"]},"refs":{"pmids":["27394191"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":41,"n":99},"commonTop":["Upper respiratory tract infection","Pyrexia","Gastroenteritis","Irritability","Decreased appetite"]}}